[1]
Floriach-Robert M, Cabello A, Simón De Las Heras R, Mateos Beato F. [Neonatal hypotonia of muscular origin: analysis of 50 cases]. Neurologia (Barcelona, Spain). 2001 Jun-Jul:16(6):245-53
[PubMed PMID: 11423041]
Level 3 (low-level) evidence
[2]
Yiu EM, Kornberg AJ. Duchenne muscular dystrophy. Journal of paediatrics and child health. 2015 Aug:51(8):759-64. doi: 10.1111/jpc.12868. Epub 2015 Mar 9
[PubMed PMID: 25752877]
[3]
Zapata-Aldana E, Ceballos-Sáenz D, Hicks R, Campbell C. Prenatal, Neonatal, and Early Childhood Features in Congenital Myotonic Dystrophy. Journal of neuromuscular diseases. 2018:5(3):331-340. doi: 10.3233/JND-170277. Epub
[PubMed PMID: 30010141]
[4]
Shieh PB. Muscular dystrophies and other genetic myopathies. Neurologic clinics. 2013 Nov:31(4):1009-29. doi: 10.1016/j.ncl.2013.04.004. Epub
[PubMed PMID: 24176421]
[5]
Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette N. A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2016 Jan:43(1):163-77. doi: 10.1017/cjn.2015.311. Epub
[PubMed PMID: 26786644]
Level 1 (high-level) evidence
[6]
Okada M, Kawahara G, Noguchi S, Sugie K, Murayama K, Nonaka I, Hayashi YK, Nishino I. Primary collagen VI deficiency is the second most common congenital muscular dystrophy in Japan. Neurology. 2007 Sep 4:69(10):1035-42
[PubMed PMID: 17785673]
[7]
Schorling DC, Kirschner J, Bönnemann CG. Congenital Muscular Dystrophies and Myopathies: An Overview and Update. Neuropediatrics. 2017 Aug:48(4):247-261. doi: 10.1055/s-0037-1604154. Epub 2017 Jul 2
[PubMed PMID: 28669131]
Level 3 (low-level) evidence
[8]
Kobayashi O, Hayashi Y, Arahata K, Ozawa E, Nonaka I. Congenital muscular dystrophy: Clinical and pathologic study of 50 patients with the classical (Occidental) merosin-positive form. Neurology. 1996 Mar:46(3):815-8
[PubMed PMID: 8618689]
[9]
Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromuscular disorders : NMD. 1995 Jul:5(4):301-5
[PubMed PMID: 7580243]
[10]
Bönnemann CG. The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy. Handbook of clinical neurology. 2011:101():81-96. doi: 10.1016/B978-0-08-045031-5.00005-0. Epub
[PubMed PMID: 21496625]
[11]
Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, Tomé FM, Schwartz K, Fardeau M, Tryggvason K. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature genetics. 1995 Oct:11(2):216-8
[PubMed PMID: 7550355]
[12]
Falsaperla R, Praticò AD, Ruggieri M, Parano E, Rizzo R, Corsello G, Vitaliti G, Pavone P. Congenital muscular dystrophy: from muscle to brain. Italian journal of pediatrics. 2016 Aug 31:42(1):78. doi: 10.1186/s13052-016-0289-9. Epub 2016 Aug 31
[PubMed PMID: 27576556]
[13]
Ishigaki K, Ihara C, Nakamura H, Mori-Yoshimura M, Maruo K, Taniguchi-Ikeda M, Kimura E, Murakami T, Sato T, Toda T, Kaiya H, Osawa M. National registry of patients with Fukuyama congenital muscular dystrophy in Japan. Neuromuscular disorders : NMD. 2018 Oct:28(10):885-893. doi: 10.1016/j.nmd.2018.08.001. Epub 2018 Aug 10
[PubMed PMID: 30220444]
[14]
Sparks SE. Neonatal hypotonia. Clinics in perinatology. 2015 Jun:42(2):363-71, ix. doi: 10.1016/j.clp.2015.02.008. Epub
[PubMed PMID: 26042909]
[15]
Barraza-Flores P, Bates CR, Oliveira-Santos A, Burkin DJ. Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics. Frontiers in molecular neuroscience. 2020:13():1. doi: 10.3389/fnmol.2020.00001. Epub 2020 Feb 11
[PubMed PMID: 32116540]
[16]
Balasubramanian M, Sayers R, Martindale J. Congenital myotonic dystrophy: natural disease progression and facial dysmorphology. Clinical dysmorphology. 2014 Oct:23(4):127-9. doi: 10.1097/MCD.0000000000000053. Epub
[PubMed PMID: 25144154]